Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Abcellera Biologics Inc ABCL

Healthcare Biotechnology
AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ABCL)

AbCellera Reports Q3 2025 Business Results

Business Wire 1 day ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Business Wire October 7, 2025

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Business Wire September 29, 2025

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Business Wire September 10, 2025

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Business Wire August 27, 2025

AbCellera to Participate at Upcoming Investor Conferences in September

Business Wire August 12, 2025

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Business Wire August 7, 2025

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Business Wire July 7, 2025

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

Business Wire May 30, 2025
View More News ››

Opinion & Analysis (NDAQ:ABCL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ABCL)

RE:Abcellera Breakout

Relax - back to normal now. I've always been curious about ABCL becauwse one of its owned buidlings is just a few blocks from me...
zalmonella - 20 hours ago

RE:Abcellera Breakout

I will do some research and try to understand the market's bull case for this. The stock IPO Was >$50 and fell to <$2 last May ...
throwaway11 - 12 days ago

Abcellera Breakout

Doesn't anyone know why it's ripping higher? It's catching fire. 
Bullknit101 - October 1, 2025

The Palantir of Biologics ?

AbCellera has been referred to this. Can someone she some light on this? My only concern is timing. Phased trials take a while and they...
Bullknit101 - July 22, 2025

AbCellera Beating S&P

https://x.com/arny_trezzi/status/1946190948137927088
Bullknit101 - July 22, 2025

Watch

TLT Theralase.
kammen83 - June 24, 2025
View more Bullboard ››

Calima Energy Ltd

Calima Energy Ltd

Calima Energy Limited is an Australia-based production-focused energy company. The Company is engaged in the exploration and ...
View More »